TOP Ships Quote - TOPS | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
AMEX
TOP Ships Inc (TOPS) Share Price

TOP Ships Inc (TOPS)

5.9268

-0.2032

(-3.31%)

Closed 18 December 8:00AM

Delayed by 15 minutes

5.9268

0.00

(0.00%)

After Hours: 11:08AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

5.9268

Bid

-

Offer

-

Volume

16,846

5.8798 Day's Range 6.1684

5.765 52 Week Range 14.24

Previous Close

6.13

Open

5.95

Last Trade

Last Trade Time

Average Volume (3m)

8,337

Financial Volume

US$ 101,168

VWAP

6.0055

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Top Ships Inc. Announces Time Charter Extensions at Very Strong Rates and Revenue of $100 Million

ATHENS, Greece, July 25, 2024 (GLOBE NEWSWIRE) -- TOP Ships Inc. (NYSE: TOPS) (the “Company”), an international owner and operator of modern, fuel efficient "ECO" tanker vessels, announced today...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

TOP Ships Announces Likely PFIC Status for 2009

ATHENS, Greece, Oct. 20 /PRNewswire-FirstCall/ -- TOP Ships Inc. (NASDAQ: TOPS) (the "Company") today announced that it expects to be treated as a passive foreign investment company, or PFIC...

TOP Ships Announces Results of Its 2009 Annual General Meeting of Shareholders

ATHENS, Greece, Sept. 10 /PRNewswire-FirstCall/ -- TOP Ships Inc. (NASDAQ: TOPS) today announced the results of its 2009 annual general meeting of shareholders. At the meeting, Marios...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.0632	-15.2103004292	6.99	7	5.765	12319	6.34801677	CS
4	-1.5732	-20.976	7.5	8.25	5.765	10024	7.12745349	CS
12	-2.7432	-31.6401384083	8.67	9.41	5.765	8337	7.90902208	CS
26	-6.1432	-50.8964374482	12.07	12.09	5.765	8989	9.0031088	CS
52	-6.5832	-52.623501199	12.51	14.24	5.765	9740	10.0978724	CS
156	-6.5832	-52.623501199	12.51	14.24	5.765	9740	10.0978724	CS
260	-6.5832	-52.623501199	12.51	14.24	5.765	9740	10.0978724	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SYNXSilynxcom Ltd	US$ 3.97 (37.46%)	484.7k
OSTXOS Therapies Incorporated	US$ 4.71 (35.34%)	670.64k
YCBDcbdMD Inc	US$ 0.438999 (29.12%)	1.79M
CVMCel Sci Corporation New	US$ 0.7636 (17.48%)	841.17k
MRTMarti Technologies Inc	US$ 3.20 (15.11%)	80.42k
UAVSAgEagle Aerial Systems Inc	US$ 5.545 (-18.70%)	1.31M
TMFMMotley Fool Midcap Growth ETF	US$ 26.84 (-14.30%)	10.02k
UMACUnusual Machines Inc	US$ 11.307 (-13.62%)	3.95M
MYNDMynd ai Inc	US$ 1.871 (-13.38%)	95.07k
MMAMixed Martial Arts Group Limited	US$ 1.25 (-12.59%)	20.48k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 1.9248 (-7.24%)	95.77M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.75 (2.60%)	70.62M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 31.13 (-4.24%)	64.5M
SPYSPDR S&P 500	US$ 604.29 (-0.41%)	54.97M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 5.84 (1.39%)	52.47M

JMoneyHoops

JMoneyHoops 1 minute ago

Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ

dstock07734

dstock07734 1 minute ago

KILLAZILLA

KILLAZILLA 2 minutes ago

DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......

gitreal

gitreal 2 minutes ago

...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i

flipper44

flipper44 3 minutes ago

Those people know we can still see them, right?

awesomed007

awesomed007 3 minutes ago

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

awesomed007

awesomed007 3 minutes ago

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

Eatatjoes

Eatatjoes 3 minutes ago

Paul Malec of Deer Park, NY

fuagf

fuagf 4 minutes ago

Yeps, yeps and yeps. Good ones.

NoMoDo

NoMoDo 4 minutes ago

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.

manibiotech

manibiotech 4 minutes ago

Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you

1vman

1vman 4 minutes ago

*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔

janice shell

janice shell 5 minutes ago

First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so

HappyAlways

HappyAlways 6 minutes ago

I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t

TheDane

TheDane 6 minutes ago

Not only did it hold but it’s on the way back up.

OnTrack444

OnTrack444 6 minutes ago

Might see a dime after the RS!

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!! Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!! GLTY

manibiotech

manibiotech 7 minutes ago

Interesting for sure but not conclusive which he repeat every day

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience

FACT-MASTER

FACT-MASTER 8 minutes ago

Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i

arizona1

arizona1 9 minutes ago

Never trumpers are hilarious and brilliant too.

jimr1717

jimr1717 10 minutes ago

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is

NoMoDo

NoMoDo 11 minutes ago

If we don't see a dime, I will be shocked.

Slyhunter

Slyhunter 11 minutes ago

I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is

nfrequent

nfrequent 11 minutes ago

Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/

XMaster2023

XMaster2023 11 minutes ago

Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions